RxDoctor Payments Data

Sharon Herndon

Nurse Practitioner · Missoula, MTNPI 1558884064

Payments from drug & device makers

$455in general payments, 2019–2025

Across 18 payments — averaging $25.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$108
  • Exact Sciences$72
  • Boehringer Ingelheim$56
  • Amgen$52
  • Lilly USA, LLC$40
  • Insulet Corporation$40
  • plus $87 from 3 others

What the payments were for

  • Food & beverage$455100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$455 in reported general payments places this provider in the 80th percentile of 357 nurse practitioner providers in Montana.

See all nurse practitioner providers in Montana

Medicare billing

Part B allowed, 2024
$45,536
Medicare patients
374
Services billed
693

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide14$18,237
OzempicSemaglutide15$13,111
PaxlovidNirmatrelvir/Ritonavir17$2,797
Doxycycline Hyclate49$429
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav24$292
Levothyroxine Sodium30$252
Omeprazole20$184
Gabapentin12$169
Lisinopril24$133
Ciprofloxacin Hcl31$93
Cephalexin23$93
Losartan Potassium14$74
Atorvastatin Calcium24$61
Prednisone19$39
Citalopram HbrCitalopram Hydrobromide12$18

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$40$18,23714 claims
PfizerPaxlovid$37$2,79717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 357 nurse practitioner providers in Montana.

Other nurse practitioner in Missoula

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →